LeMaitre Vascular (LMAT 1.52%), a medical device company focused on vascular surgeons, reported its latest quarterly earnings after the bell on August 5, 2025. The company delivered GAAP results ahead of expectations, posting GAAP earnings per share of $0.60, above the anticipated$0.57 (GAAP). Revenue (GAAP) reached $64.2 million for Q2 2025, beating GAAP revenue forecasts of$62.48 million and rising significantly from the prior-year total of $55.8 million (GAAP, Q2 2024). Gross margin (GAAP) improved and ...